10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2022 | |||
Consolidated Statements of Operations | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 24, 2023) | |||
| (In Millions) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Revenues: | |||
| Premiums | $ 257,157 | 226,233 | 201,478 |
| Investment and other income | 2,030 | 2,324 | 1,502 |
| Total revenues | 324,162 | 287,597 | 257,141 |
| Operating costs: | |||
| Medical costs | 210,842 | 186,911 | 159,396 |
| Operating costs | 47,782 | 42,579 | 41,704 |
| Cost of products sold | 33,703 | 31,034 | 30,745 |
| Depreciation and amortization | 3,400 | 3,103 | 2,891 |
| Total operating costs | 295,727 | 263,627 | 234,736 |
| Earnings from operations | 28,435 | 23,970 | 22,405 |
| Interest expense | (2,092) | (1,660) | (1,663) |
| Earnings before income taxes | 26,343 | 22,310 | 20,742 |
| Provision for income taxes | (5,704) | (4,578) | (4,973) |
| Net earnings | 20,639 | 17,732 | 15,769 |
| Earnings attributable to noncontrolling interests | (519) | (447) | (366) |
| Net earnings attributable to UnitedHealth Group common shareholders | 20,120 | 17,285 | 15,403 |
| Earnings per share attributable to UnitedHealth Group common shareholders: | |||
| Basic | 21.47 | 18.33 | 16.23 |
| Diluted | 21.18 | 18.08 | 16.03 |
| Basic weighted-average number of common shares outstanding | 937 | 943 | 949 |
| Dilutive effect of common share equivalents | 13 | 13 | 12 |
| Diluted weighted-average number of common shares outstanding | 950 | 956 | 961 |
| Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents | 3 | 1 | 8 |
| Product and Service | |||
| Products | |||
| Revenue from Products and Services | 37,424 | 34,437 | 34,145 |
| Services | |||
| Revenue from Products and Services | 27,551 | 24,603 | 20,016 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2022 | |||
Consolidated Statements of Comprehensive Income | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 24, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Net earnings | $ 20,639 | 17,732 | 15,769 |
| Other comprehensive loss: | |||
| Gross unrealized (losses) gains on investment securities during the period | (4,292) | (1,028) | 1,058 |
| Income tax effect | 984 | 248 | (253) |
| Total unrealized (losses) gains, net of tax | (3,308) | (780) | 805 |
| Gross reclassification adjustment for net realized losses (gains) included in net earnings | 139 | (173) | (75) |
| Income tax effect | (32) | 40 | 17 |
| Total reclassification adjustment, net of tax | 107 | (133) | (58) |
| Total foreign currency translation gains (losses) | 192 | (657) | (983) |
| Other comprehensive loss | (3,009) | (1,570) | (236) |
| Comprehensive income | 17,630 | 16,162 | 15,533 |
| Comprehensive income attributable to noncontrolling interests | (519) | (447) | (366) |
| Comprehensive income attributable to UnitedHealth Group common shareholders | 17,111 | 15,715 | 15,167 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
UNITEDHEALTH GROUP INC | |||
Ticker: UNH Fiscal Year: 2022 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2022 10-K (Filed: Feb 24, 2023) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |
| Operating activities | |||
| Net earnings | $ 20,639 | 17,732 | 15,769 |
| Noncash items: | |||
| Depreciation and amortization | 3,400 | 3,103 | 2,891 |
| Deferred income taxes | (673) | 130 | (8) |
| Share-based compensation | 925 | 800 | 679 |
| Other, net | (331) | (944) | (52) |
| Net change in other operating items, net of effects from acquisitions and changes in AARP balances: | |||
| Accounts receivable | (2,523) | (1,000) | (688) |
| Other assets | (1,374) | (1,031) | (2,195) |
| Medical costs payable | 4,053 | 2,701 | 152 |
| Accounts payable and other liabilities | 1,964 | 1,162 | 5,348 |
| Unearned revenues | 126 | (310) | 278 |
| Cash flows from operating activities | 26,206 | 22,343 | 22,174 |
| Investing activities | |||
| Purchases of investments | (18,825) | (17,139) | (16,577) |
| Sales of investments | 5,907 | 7,045 | 6,489 |
| Maturities of investments | 6,081 | 8,251 | 7,252 |
| Cash paid for acquisitions, net of cash assumed | (21,458) | (4,821) | (7,139) |
| Purchases of property, equipment and capitalized software | (2,802) | (2,454) | (2,051) |
| Cash received from dispositions | 3,414 | 15 | 221 |
| Other, net | (793) | (1,269) | (727) |
| Cash flows used for investing activities | (28,476) | (10,372) | (12,532) |
| Financing activities | |||
| Common share repurchases | (7,000) | (5,000) | (4,250) |
| Cash dividends paid | (5,991) | (5,280) | (4,584) |
| Proceeds from common stock issuances | 1,253 | 1,355 | 1,440 |
| Repayments of long-term debt | (3,015) | (3,150) | (3,150) |
| Proceeds from (repayments of) short-term borrowings, net | 732 | (1,302) | 872 |
| Proceeds from issuance of long-term debt | 14,819 | 6,933 | 4,864 |
| Customer funds administered | 5,548 | 622 | 1,677 |
| Purchases of redeemable noncontrolling interests | (176) | (1,338) | 0 |
| Other, net | (1,944) | (295) | (459) |
| Cash flows from (used for) financing activities | 4,226 | (7,455) | (3,590) |
| Effect of exchange rate changes on cash and cash equivalents | 34 | (62) | (116) |
| Increase in cash and cash equivalents | 1,990 | 4,454 | 5,936 |
| Cash and cash equivalents, beginning of period | 21,375 | 16,921 | |
| Cash and cash equivalents, end of period | 23,365 | 21,375 | 16,921 |
| Supplemental cash flow disclosures | |||
| Cash paid for interest | 1,945 | 1,653 | 1,704 |
| Cash paid for income taxes | 5,222 | 3,966 | 4,935 |
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
UNITEDHEALTH GROUP INC | ||
Ticker: UNH Fiscal Year: 2022 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2022 10-K (Filed: Feb 24, 2023) | ||
| (In Millions) | ||
| As of | As of | |
| Dec 31, 2022 | Dec 31, 2021 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $ 23,365 | 21,375 |
| Short-term investments | 4,546 | 2,532 |
| Accounts receivable, net of allowances of $877 and $954 | 17,681 | 14,216 |
| Other current receivables, net of allowances of $1,433 and $993 | 12,769 | 13,866 |
| Assets under management | 4,087 | 4,449 |
| Prepaid expenses and other current assets | 6,621 | 5,320 |
| Total current assets | 69,069 | 61,758 |
| Long-term investments | 43,728 | 43,114 |
| Property, equipment and capitalized software, net of accumulated depreciation and amortization of $6,930 and $5,992 | 10,128 | 8,969 |
| Goodwill | 93,352 | 75,795 |
| Other intangible assets, net of accumulated amortization of $6,137 and $5,636 | 14,401 | 10,044 |
| Other assets | 15,027 | 12,526 |
| Total assets | 245,705 | 212,206 |
| Liabilities, redeemable noncontrolling interests and equity | ||
| Current liabilities: | ||
| Medical costs payable | 29,056 | 24,483 |
| Accounts payable and accrued liabilities | 27,715 | 24,643 |
| Short-term borrowings and current maturities of long-term debt | 3,110 | 3,620 |
| Unearned revenues | 3,075 | 2,571 |
| Other current liabilities | 26,281 | 22,975 |
| Total current liabilities | 89,237 | 78,292 |
| Long-term debt, less current maturities | 54,513 | 42,383 |
| Deferred income taxes | 2,769 | 3,265 |
| Other liabilities | 12,839 | 11,787 |
| Total liabilities | 159,358 | 135,727 |
| Commitments and contingencies (Note 12) | ||
| Redeemable noncontrolling interests | 4,897 | 1,434 |
| Equity: | ||
| Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding | 0 | 0 |
| Common stock, $0.01 par value - 3,000 shares authorized; 934 and 941 issued and outstanding | 9 | 10 |
| Retained earnings | 86,156 | 77,134 |
| Accumulated other comprehensive loss | (8,393) | (5,384) |
| Nonredeemable noncontrolling interests | 3,678 | 3,285 |
| Total equity | 81,450 | 75,045 |
| Total liabilities, redeemable noncontrolling interests and equity | 245,705 | 212,206 |
| Preferred stock, par value | 0.001 | 0.001 |
| Preferred stock, shares authorized | 10 | 10 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value | 0.010 | 0.010 |
| Common stock, shares authorized | 3,000 | 3,000 |
| Common stock, shares issued | 934 | 941 |
| Common Stock, Shares, Outstanding | 934 | 941 |
| External Links | |
| UNITEDHEALTH GROUP INC (UNH) Fiscal Year 2022 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |